(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
1d
GlobalData on MSNFDA clears Hologic’s Aptima SARS-CoV-2 assayHologic's Panther system, on which the assay runs, processes the samples, delivering initial outcomes in under three hours.
Coronary artery lesions in patients with SARS-CoV-2 infection more likely to become high-risk plaques. HealthDay News — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is ...
A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...
The following is a summary of “Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis,” published in ...
SARS-CoV-2 risk is lower among children aged younger than 5 who had vs did not have prior infection, regardless of vaccination status.
A new portable and wireless device can detect SARS-CoV-2 and vitamin C, a critical nutrient that helps bolster infection ...
14d
News Medical on MSNNatural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergenceFindings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance protection against reinfection.
In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...
A Weill Cornell Medicine-Qatar study found that SARS-CoV-2 evolved from prioritizing transmission to evading immunity after the Omicron variant emerged. Before Omicron, natural immunity from prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results